CLINICAL_TRIALS trial_result · 2021-04-15

Clinical Trial Update: A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma [Phase 2]

Phase 2 trial investigating high-dose chemoradiation with biologically-based target volume definition in glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2021-04-15